PubMed:19131502 JSONTXT

Annnotations TAB JSON ListView MergeView

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":76},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":77,"end":87},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":88,"end":240},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":241,"end":262},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":263,"end":506},"obj":"Sentence"},{"id":"TextSentencer_T6","span":{"begin":507,"end":680},"obj":"Sentence"},{"id":"TextSentencer_T7","span":{"begin":681,"end":855},"obj":"Sentence"},{"id":"TextSentencer_T8","span":{"begin":856,"end":905},"obj":"Sentence"},{"id":"TextSentencer_T9","span":{"begin":906,"end":1004},"obj":"Sentence"},{"id":"TextSentencer_T10","span":{"begin":1005,"end":1013},"obj":"Sentence"},{"id":"TextSentencer_T11","span":{"begin":1014,"end":1085},"obj":"Sentence"},{"id":"TextSentencer_T12","span":{"begin":1086,"end":1146},"obj":"Sentence"},{"id":"TextSentencer_T13","span":{"begin":1147,"end":1253},"obj":"Sentence"},{"id":"TextSentencer_T14","span":{"begin":1254,"end":1336},"obj":"Sentence"},{"id":"TextSentencer_T15","span":{"begin":1337,"end":1441},"obj":"Sentence"},{"id":"TextSentencer_T16","span":{"begin":1442,"end":1454},"obj":"Sentence"},{"id":"TextSentencer_T17","span":{"begin":1455,"end":1582},"obj":"Sentence"},{"id":"TextSentencer_T18","span":{"begin":1583,"end":1723},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":76},"obj":"Sentence"},{"id":"T2","span":{"begin":77,"end":87},"obj":"Sentence"},{"id":"T3","span":{"begin":88,"end":240},"obj":"Sentence"},{"id":"T4","span":{"begin":241,"end":262},"obj":"Sentence"},{"id":"T5","span":{"begin":263,"end":506},"obj":"Sentence"},{"id":"T6","span":{"begin":507,"end":680},"obj":"Sentence"},{"id":"T7","span":{"begin":681,"end":855},"obj":"Sentence"},{"id":"T8","span":{"begin":856,"end":905},"obj":"Sentence"},{"id":"T9","span":{"begin":906,"end":1004},"obj":"Sentence"},{"id":"T10","span":{"begin":1005,"end":1013},"obj":"Sentence"},{"id":"T11","span":{"begin":1014,"end":1085},"obj":"Sentence"},{"id":"T12","span":{"begin":1086,"end":1146},"obj":"Sentence"},{"id":"T13","span":{"begin":1147,"end":1253},"obj":"Sentence"},{"id":"T14","span":{"begin":1254,"end":1336},"obj":"Sentence"},{"id":"T15","span":{"begin":1337,"end":1441},"obj":"Sentence"},{"id":"T16","span":{"begin":1442,"end":1454},"obj":"Sentence"},{"id":"T17","span":{"begin":1455,"end":1582},"obj":"Sentence"},{"id":"T18","span":{"begin":1583,"end":1723},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Screening for membrane hormone receptor expression in primary aldosteronism.\nOBJECTIVE: The investigation of expression and functional relevance of G-protein coupled receptors in primary aldosteronism (PA) by molecular and clinical studies.\nPATIENTS AND METHODS: Tissues of 14 aldosterone-producing adenomas (APA), of one unilateral adrenal hyperplasia and of six healthy adult adrenal glands; 12 patients with confirmed PA due to APA; (n=5), idiopathic hyperaldosteronism (n=7) and 8 control subjects (C). The tissues were subjected to a quantitative PCR for determination of mRNA expression levels of AT2R1, GIPR, MC2R, GnRHR, LHR, TRHR, TSHR, glucagon-R, V1aR, V2R, and 5-HT4R. The patients and controls were enrolled in a test protocol consisting of stimulation by posture, mixed meal, ACTH, GnRH, TRH, glucagon, vasopressin, and metoclopramide (MCP). Three patients could be analyzed by both studies. A positive response was defined as an aldosterone increase of more than 50% following stimulation.\nRESULTS: All the tissues revealed AT2R1, MC2R, AVPR, and 5-HT4R mRNA expression. LHR mRNA was found in normal adrenals and 13 adrenal tumors. By contrast with normal adrenals tumorous adrenal tissue expressed GnRHR mRNA (4/15) and TSHR mRNA (1/15). Both the patients and controls responded to posture, ACTH, glucagon, AVP, and MCP. Specific responses were seen in one patient following TRH and three patients following GnRH stimulation.\nCONCLUSIONS: We provide evidence for peptide hormone responsiveness to various peptide hormones in patients with PA, including GnRH and TRH. A good correlation between clinical and molecular testing could be observed, making an involvement of the receptor expressed in PA possible."}

    DisGeNET

    {"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":1086,"end":1089},"obj":"gene:3973"},{"id":"T1","span":{"begin":1131,"end":1145},"obj":"disease:C0001624"},{"id":"T2","span":{"begin":1086,"end":1089},"obj":"gene:960"},{"id":"T3","span":{"begin":1131,"end":1145},"obj":"disease:C0001624"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"},{"id":"R2","pred":"associated_with","subj":"T2","obj":"T3"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Screening for membrane hormone receptor expression in primary aldosteronism.\nOBJECTIVE: The investigation of expression and functional relevance of G-protein coupled receptors in primary aldosteronism (PA) by molecular and clinical studies.\nPATIENTS AND METHODS: Tissues of 14 aldosterone-producing adenomas (APA), of one unilateral adrenal hyperplasia and of six healthy adult adrenal glands; 12 patients with confirmed PA due to APA; (n=5), idiopathic hyperaldosteronism (n=7) and 8 control subjects (C). The tissues were subjected to a quantitative PCR for determination of mRNA expression levels of AT2R1, GIPR, MC2R, GnRHR, LHR, TRHR, TSHR, glucagon-R, V1aR, V2R, and 5-HT4R. The patients and controls were enrolled in a test protocol consisting of stimulation by posture, mixed meal, ACTH, GnRH, TRH, glucagon, vasopressin, and metoclopramide (MCP). Three patients could be analyzed by both studies. A positive response was defined as an aldosterone increase of more than 50% following stimulation.\nRESULTS: All the tissues revealed AT2R1, MC2R, AVPR, and 5-HT4R mRNA expression. LHR mRNA was found in normal adrenals and 13 adrenal tumors. By contrast with normal adrenals tumorous adrenal tissue expressed GnRHR mRNA (4/15) and TSHR mRNA (1/15). Both the patients and controls responded to posture, ACTH, glucagon, AVP, and MCP. Specific responses were seen in one patient following TRH and three patients following GnRH stimulation.\nCONCLUSIONS: We provide evidence for peptide hormone responsiveness to various peptide hormones in patients with PA, including GnRH and TRH. A good correlation between clinical and molecular testing could be observed, making an involvement of the receptor expressed in PA possible."}

    DisGeNET5_gene_disease

    {"project":"DisGeNET5_gene_disease","denotations":[{"id":"19131502-8#0#3#gene960","span":{"begin":1086,"end":1089},"obj":"gene960"},{"id":"19131502-8#0#3#gene3973","span":{"begin":1086,"end":1089},"obj":"gene3973"},{"id":"19131502-8#45#59#diseaseC0001624","span":{"begin":1131,"end":1145},"obj":"diseaseC0001624"}],"relations":[{"id":"0#3#gene96045#59#diseaseC0001624","pred":"associated_with","subj":"19131502-8#0#3#gene960","obj":"19131502-8#45#59#diseaseC0001624"},{"id":"0#3#gene397345#59#diseaseC0001624","pred":"associated_with","subj":"19131502-8#0#3#gene3973","obj":"19131502-8#45#59#diseaseC0001624"}],"text":"Screening for membrane hormone receptor expression in primary aldosteronism.\nOBJECTIVE: The investigation of expression and functional relevance of G-protein coupled receptors in primary aldosteronism (PA) by molecular and clinical studies.\nPATIENTS AND METHODS: Tissues of 14 aldosterone-producing adenomas (APA), of one unilateral adrenal hyperplasia and of six healthy adult adrenal glands; 12 patients with confirmed PA due to APA; (n=5), idiopathic hyperaldosteronism (n=7) and 8 control subjects (C). The tissues were subjected to a quantitative PCR for determination of mRNA expression levels of AT2R1, GIPR, MC2R, GnRHR, LHR, TRHR, TSHR, glucagon-R, V1aR, V2R, and 5-HT4R. The patients and controls were enrolled in a test protocol consisting of stimulation by posture, mixed meal, ACTH, GnRH, TRH, glucagon, vasopressin, and metoclopramide (MCP). Three patients could be analyzed by both studies. A positive response was defined as an aldosterone increase of more than 50% following stimulation.\nRESULTS: All the tissues revealed AT2R1, MC2R, AVPR, and 5-HT4R mRNA expression. LHR mRNA was found in normal adrenals and 13 adrenal tumors. By contrast with normal adrenals tumorous adrenal tissue expressed GnRHR mRNA (4/15) and TSHR mRNA (1/15). Both the patients and controls responded to posture, ACTH, glucagon, AVP, and MCP. Specific responses were seen in one patient following TRH and three patients following GnRH stimulation.\nCONCLUSIONS: We provide evidence for peptide hormone responsiveness to various peptide hormones in patients with PA, including GnRH and TRH. A good correlation between clinical and molecular testing could be observed, making an involvement of the receptor expressed in PA possible."}

    DisGeNet-2017-sample

    {"project":"DisGeNet-2017-sample","denotations":[{"id":"T1519","span":{"begin":1086,"end":1089},"obj":"gene:960"},{"id":"T1520","span":{"begin":1131,"end":1145},"obj":"disease:C0001624"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T1519","obj":"T1520"},{"id":"R2","pred":"associated_with","subj":"T1519","obj":"T1520"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Screening for membrane hormone receptor expression in primary aldosteronism.\nOBJECTIVE: The investigation of expression and functional relevance of G-protein coupled receptors in primary aldosteronism (PA) by molecular and clinical studies.\nPATIENTS AND METHODS: Tissues of 14 aldosterone-producing adenomas (APA), of one unilateral adrenal hyperplasia and of six healthy adult adrenal glands; 12 patients with confirmed PA due to APA; (n=5), idiopathic hyperaldosteronism (n=7) and 8 control subjects (C). The tissues were subjected to a quantitative PCR for determination of mRNA expression levels of AT2R1, GIPR, MC2R, GnRHR, LHR, TRHR, TSHR, glucagon-R, V1aR, V2R, and 5-HT4R. The patients and controls were enrolled in a test protocol consisting of stimulation by posture, mixed meal, ACTH, GnRH, TRH, glucagon, vasopressin, and metoclopramide (MCP). Three patients could be analyzed by both studies. A positive response was defined as an aldosterone increase of more than 50% following stimulation.\nRESULTS: All the tissues revealed AT2R1, MC2R, AVPR, and 5-HT4R mRNA expression. LHR mRNA was found in normal adrenals and 13 adrenal tumors. By contrast with normal adrenals tumorous adrenal tissue expressed GnRHR mRNA (4/15) and TSHR mRNA (1/15). Both the patients and controls responded to posture, ACTH, glucagon, AVP, and MCP. Specific responses were seen in one patient following TRH and three patients following GnRH stimulation.\nCONCLUSIONS: We provide evidence for peptide hormone responsiveness to various peptide hormones in patients with PA, including GnRH and TRH. A good correlation between clinical and molecular testing could be observed, making an involvement of the receptor expressed in PA possible."}

    UBERON-AE

    {"project":"UBERON-AE","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":263,"end":270},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"PD-UBERON-AE-B_T2","span":{"begin":511,"end":518},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"PD-UBERON-AE-B_T3","span":{"begin":1022,"end":1029},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"PD-UBERON-AE-B_T4","span":{"begin":1197,"end":1203},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"PD-UBERON-AE-B_T5","span":{"begin":378,"end":392},"obj":"http://purl.obolibrary.org/obo/UBERON_0002369"},{"id":"PD-UBERON-AE-B_T6","span":{"begin":386,"end":392},"obj":"http://purl.obolibrary.org/obo/UBERON_0002530"},{"id":"PD-UBERON-AE-B_T7","span":{"begin":1189,"end":1203},"obj":"http://purl.obolibrary.org/obo/UBERON_0018303"}],"text":"Screening for membrane hormone receptor expression in primary aldosteronism.\nOBJECTIVE: The investigation of expression and functional relevance of G-protein coupled receptors in primary aldosteronism (PA) by molecular and clinical studies.\nPATIENTS AND METHODS: Tissues of 14 aldosterone-producing adenomas (APA), of one unilateral adrenal hyperplasia and of six healthy adult adrenal glands; 12 patients with confirmed PA due to APA; (n=5), idiopathic hyperaldosteronism (n=7) and 8 control subjects (C). The tissues were subjected to a quantitative PCR for determination of mRNA expression levels of AT2R1, GIPR, MC2R, GnRHR, LHR, TRHR, TSHR, glucagon-R, V1aR, V2R, and 5-HT4R. The patients and controls were enrolled in a test protocol consisting of stimulation by posture, mixed meal, ACTH, GnRH, TRH, glucagon, vasopressin, and metoclopramide (MCP). Three patients could be analyzed by both studies. A positive response was defined as an aldosterone increase of more than 50% following stimulation.\nRESULTS: All the tissues revealed AT2R1, MC2R, AVPR, and 5-HT4R mRNA expression. LHR mRNA was found in normal adrenals and 13 adrenal tumors. By contrast with normal adrenals tumorous adrenal tissue expressed GnRHR mRNA (4/15) and TSHR mRNA (1/15). Both the patients and controls responded to posture, ACTH, glucagon, AVP, and MCP. Specific responses were seen in one patient following TRH and three patients following GnRH stimulation.\nCONCLUSIONS: We provide evidence for peptide hormone responsiveness to various peptide hormones in patients with PA, including GnRH and TRH. A good correlation between clinical and molecular testing could be observed, making an involvement of the receptor expressed in PA possible."}

    performance-test

    {"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":378,"end":392},"obj":"http://purl.obolibrary.org/obo/UBERON_0002369"},{"id":"PD-UBERON-AE-B_T2","span":{"begin":386,"end":392},"obj":"http://purl.obolibrary.org/obo/UBERON_0002530"},{"id":"PD-UBERON-AE-B_T3","span":{"begin":263,"end":270},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"PD-UBERON-AE-B_T4","span":{"begin":511,"end":518},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"PD-UBERON-AE-B_T5","span":{"begin":1022,"end":1029},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"PD-UBERON-AE-B_T6","span":{"begin":1197,"end":1203},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"PD-UBERON-AE-B_T7","span":{"begin":1189,"end":1203},"obj":"http://purl.obolibrary.org/obo/UBERON_0018303"}],"text":"Screening for membrane hormone receptor expression in primary aldosteronism.\nOBJECTIVE: The investigation of expression and functional relevance of G-protein coupled receptors in primary aldosteronism (PA) by molecular and clinical studies.\nPATIENTS AND METHODS: Tissues of 14 aldosterone-producing adenomas (APA), of one unilateral adrenal hyperplasia and of six healthy adult adrenal glands; 12 patients with confirmed PA due to APA; (n=5), idiopathic hyperaldosteronism (n=7) and 8 control subjects (C). The tissues were subjected to a quantitative PCR for determination of mRNA expression levels of AT2R1, GIPR, MC2R, GnRHR, LHR, TRHR, TSHR, glucagon-R, V1aR, V2R, and 5-HT4R. The patients and controls were enrolled in a test protocol consisting of stimulation by posture, mixed meal, ACTH, GnRH, TRH, glucagon, vasopressin, and metoclopramide (MCP). Three patients could be analyzed by both studies. A positive response was defined as an aldosterone increase of more than 50% following stimulation.\nRESULTS: All the tissues revealed AT2R1, MC2R, AVPR, and 5-HT4R mRNA expression. LHR mRNA was found in normal adrenals and 13 adrenal tumors. By contrast with normal adrenals tumorous adrenal tissue expressed GnRHR mRNA (4/15) and TSHR mRNA (1/15). Both the patients and controls responded to posture, ACTH, glucagon, AVP, and MCP. Specific responses were seen in one patient following TRH and three patients following GnRH stimulation.\nCONCLUSIONS: We provide evidence for peptide hormone responsiveness to various peptide hormones in patients with PA, including GnRH and TRH. A good correlation between clinical and molecular testing could be observed, making an involvement of the receptor expressed in PA possible."}